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Poliovirus Infection Transiently Increases COPII Vesicle Budding
Meg Trahey,a Hyung Suk Oh,b* Craig E. Cameron,b and Jesse C. Haya
Division of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, Montana, USA,a and Department of
Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, USAb

Poliovirus (PV) requires membranes of the host cell’s secretory pathway to generate replication complexes (RCs) for viral RNA
synthesis. Recent work identified the intermediate compartment and the Golgi apparatus as the precursors of the replication
“organelles” of PV (N. Y. Hsu et al., Cell 141:799 – 811, 2010). In this study, we examined the effect of PV on COPII vesicles, the
secretory cargo carriers that bud from the endoplasmic reticulum and homotypically fuse to form the intermediate compartment that matures into the Golgi apparatus. We found that infection by PV results in a biphasic change in functional COPII vesicle biogenesis in cells, with an early enhancement and subsequent inhibition. Concomitant with the early increase in COPII vesicle formation, we found an increase in the membrane fraction of Sec16A, a key regulator of COPII vesicle formation. We suggest
that the early burst in COPII vesicle formation detected benefits PV by increasing the precursor pool required for the formation
of its RCs.

P

oliovirus (PV) is a member of the Picornaviridae family of
small nonenveloped positive-strand RNA viruses. Like other
positive-strand viruses, PV replicates within the host cell cytoplasm in membranous replication complexes (RCs) (23). Recent
electron tomographic studies by Belov et al. demonstrated that
these RCs are convoluted branching structures (3). Data from a
number of laboratories suggest that PV coopts the membranes of
the early secretory pathway to establish RCs (see reference 1 and
references therein). The early secretory pathway transports proteins destined for secretion from the endoplasmic reticulum (ER)
to the Golgi apparatus (20, 24). Specifically, cargo-laden COPII
vesicles bud from specialized regions of the ER, the transitional ER
or ER exit sites (ERES), and fuse homotypically to become an
ER/Golgi intermediate compartment (ERGIC) or vesicular tubular cluster (VTC) where protein sorting occurs. Resident ER proteins are returned to the ER via COPI vesicles, and proteins destined for secretion continue on to the Golgi apparatus.
The mechanistic details of COPII vesicle biogenesis have been
studied extensively. Vesicle formation is initiated by the interaction of the small GTP-binding protein Sar1 and its nucleotide
exchange factor, Sec12, on ER membranes. The exchange of GDP
for GTP on Sar1 triggers the membrane insertion of its N-terminal
amphipathic alpha helix and the binding of the inner COPII coat
subunits (Sec23/24), followed by the outer coat subunits (Sec13/
31) (16, 24). The peripheral membrane protein Sec16 is required
for this process in vivo (6, 10, 18, 31) and enhances this process in
vitro (28). Sec16 has binding sites for COPII coat proteins (10, 13,
17, 27), and it has been proposed to act as a platform for assembly
of the COPII coat (27, 31). Independent of this function, Sec16 has
also been shown to be required for the development of ERES in the
yeast Pichia pastoris (7), in Drosophila (19), and in mammalian
cells (6, 31).
Mammals have two unique genes with homology to the central
conserved domain of yeast Sec16, namely, the Sec16A and Sec16B
genes (also known as the Sec16L and -S genes [6]). The Sec16A
gene encodes a protein of ⬃250 kDa, a similar size to that of yeast
Sec16, while the Sec16B gene encodes a much smaller protein, of
⬃117 kDa (6, 18, 31). Based on size and sequence similarity outside the central domain, Sec16A is the likely orthologue of yeast
Sec16 (6, 18, 31). Interestingly, recent work by Yonekawa et al.
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identified a unique cellular role for Sec16B: Sec16B is required for
the transport of a specific peroxisome biogenesis factor, Pex16,
from the ER to the peroxisome (33).
Rust and colleagues showed that early in PV infection, the viral
proteins 2B and 2BC colocalize with COPII coat proteins specifically at ERES (26). These data were used to support the hypothesis
that poliovirus coopts COPII vesicles for the formation of RCs.
However, recent work by Hsu et al. has shown that PV hijacks later
COPII-derived organelles of the ERGIC/Golgi apparatus, generating “remodeled” vesicles devoid of coat proteins but enriched in
phosphatidylinositol-4-phosphate lipids (14). This altered lipid
composition favors binding of the viral polymerase, facilitating
viral RNA synthesis (14). These membrane remodeling events are
critically dependent on the poliovirus membrane protein 3A and
its association with the host proteins GBF1 and Arf1. Arf1 is a
small GTP-binding protein required for assembly of COPI-coated
vesicles, and GBF1 is its guanine nucleotide exchange factor (15).
What then is the consequence of the association of PV proteins
2B and 2BC with COPII proteins at ERES? We propose that this
association supports an effect of PV infection on COPII vesicle
biogenesis. Specifically, we hypothesize that PV infection enhances COPII vesicle formation to enrich the intermediate compartment precursors used for RC formation.
MATERIALS AND METHODS
Cells, viruses, transfection, and infection. NRK (normal rat kidney) and
HeLa cells were cultured in complete Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum, penicillin, and streptomycin. NRK
cells expressing the poliovirus receptor (PVR) were generated using the
BD RevTet-Off system (BD Biosciences). Briefly, PVR cDNA (a gift from
Mattias Gromeier) was cloned into the retroviral vector pLP-RevTRE
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(pLP-RevTRE-PVR). pLP-RevTRE-PVR- and pRevTet-off-containing
retrovirus stocks were made as described previously (25). NRK cells coinfected with pLP-RevTRE-PVR- and pRevTet-off-containing retroviruses
were cultured in growth medium with 300 g/ml of hygromycin B and
G418. PVR expression was confirmed by Western blotting. The resultant
PVR-NRK cells were routinely cultured in growth medium supplemented
with 100 g/ml of hygromycin B and G418. PV type I Mahoney and
eGFP-PV (a gift from Raul Andino [8]) stocks were produced in HeLa
cells as described previously (25). Briefly, HeLa cells were electroporated
with RNA transcribed from linearized plasmid DNA and incubated at
37°C for 2 to 3 days until cytopathic effect became apparent. Infected cells
were harvested and virus particles released by three freeze-thaw cycles. For
PV infections, cells were seeded in growth medium without hygromycin
or G418 and were 90% confluent on the day of infection. Virus was added
to cells at room temperature for 30 min with occasional rocking. Cells
were washed three times with phosphate-buffered saline (PBS) to remove
unadsorbed virus, fresh growth medium was added, and cultures were
incubated at 37°C for the indicated times. For budding and fusion experiments using cells expressing the myc-tagged temperature-sensitive mutant G glycoprotein of vesicular stomatitis virus (VSV-Gts-myc), PVRNRK cells were electroporated with pVSV-Gts-myc DNA. After 3 h of
recovery at 37°C, cultures were maintained at the nonpermissive temperature of 40°C overnight. At this temperature, VSV-Gts is unable to fold
properly and accumulates in the ER.
Antibodies. The primary antibodies used were mouse anti-myc antibody
9E10 (32), rabbit anti-p24 COPII cargo receptor (4), rabbit anti-sec31A (5),
rabbit anti-sec16A (Novus), mouse anti-mannosidase II (Covance), mouse
anti-GBF1 (BD Laboratories), goat anti-PGK-1 (Y-12; Santa Cruz Biotechnology, Inc.), rabbit anti-IP3RI (Affinity BioReagents), mouse anti-IP3RIII
(BD Laboratories), rabbit anti-calnexin (Assay Designs, Inc.). Species-specific
peroxidase-, Cy5-, and Cy3-conjugated secondary antibodies were obtained
from Jackson ImmunoResearch, Inc.
Transmission electron microscopy. Mock-infected and PV-infected
PVR-NRK cells (multiplicity of infection [MOI], 20) were incubated at
37°C for 8 h, washed with PBS, and fixed with 1% glutaraldehyde for 15
min at room temperature and 60 min on ice. The sample preparation was
done essentially as described previously (25). The cell pellet was incubated
in 1% reduced osmium tetroxide containing 1% potassium ferricyanide
in 0.1 M cacodylate for 60 min, followed by en bloc staining with 3%
uranyl acetate (UA) in 50% ethanol for 60 min in the dark. After dehydration with ethanol (70 to 95%), embedding was done with 100% Epon
(Electron Microscopy Sciences) overnight at 65°C. Thin sections (60- to
90-nm thickness) were prepared and stained with UA-lead citrate. The
image was taken using a Jeol JEM 1200 EXII electron microscope in the
Electron Microscopy Facility at the Pennsylvania State University.
Budding and fusion reactions. In vitro COPII vesicle budding and
fusion reactions were performed essentially as described previously (32).
PVR-NRK cells were infected with PV as described above for various
times, washed, scrape permeabilized in 50 mM HEPES, pH 7.2, 90 mM
potassium acetate, and maintained on ice. These semi-intact permeabilized cells, the source of ER, were added to budding reaction mixtures
containing rat liver cytosol and an ATP regeneration system. The rat liver
cytosol provided necessary soluble COPII and Sar1 proteins. The specificity of the reactions for COPII vesicle formation was tested by performing parallel reactions in the presence of the dominant-negative mutant
Sar1 protein (T39N), a GDP-restricted specific inhibitor of COPII vesicle
formation (21). Reaction mixtures were incubated on ice (negative control, no budding) or at 32°C (permissive temperature for budding). Budding reactions were centrifuged at 15,000 ⫻ g to remove donor permeabilized cells, and the supernatants containing released vesicles were
centrifuged at 100,000 ⫻ g. Pellets were dissolved in SDS sample buffer,
proteins were resolved by SDS-PAGE, and the amount of vesicles formed
was determined by Western blotting using antibodies to the COPII cargo
receptor p24 (4). To measure the equivalence of permeabilized cell inputs
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to the reaction mixtures, blots were stripped and reprobed with antibodies
to the ER protein calnexin.
To assess the ability of released vesicles to fuse homotypically, we generated two distinct VSV-G-bearing vesicle populations whose identity and
mixing can be followed as diagrammed in Fig. 3. This fusion assay was
performed essentially as described previously (32) and exploits the fact
that VSV-G trimers exchange subunits only when present in the same
membrane. The first vesicle population was generated by using VSV-Gtsmyc-transfected PVR-NRK cells. These cells were infected with PV for the
indicated times and permeabilized as described above. The second vesicle
population was generated from VSV-infected and [35S]methionine-cysteine pulse-labeled cells. These cells were not infected with PV. The released vesicle population from each cell type contains about 1.3% of the
total VSV-G protein (32). The two populations were mixed and incubated
at 32°C for 1 h. Fusion permits the exchange of VSV-G subunits and
generates heterotrimers consisting of a mixture of myc-tagged unlabeled
and untagged radioactive VSV-G subunits. Under these conditions,
⬃2.5% of the released vesicular VSV-G exchanges subunits, generating
heterotrimers (32). Fusion reaction mixtures were adjusted to 2% Triton
X-100 and centrifuged at 100,000 ⫻ g. Myc-tagged VSV-G was immunoprecipitated from the 100,000 ⫻ g supernatants by use of biotinylated
9E10 monoclonal antibody and streptavidin-Sepharose (GE Healthcare).
Eluted proteins were resolved by SDS-PAGE, and heterotrimerization was
quantified following phosphorimaging to detect coprecipitated radioactive VSV-G.
Immunofluorescence. Cells were cultured in 6-well plates containing
poly-L-lysine (0.5 mg/ml)-coated coverslips. Infected cells were washed
with PBS and fixed with 4% paraformaldehyde (EM Biosciences) in PBS
for 20 min at room temperature. Free aldehydes were quenched with 100
mM glycine in PBS twice for 10 min at room temperature or overnight at
4°C. Cells were permeabilized with IF buffer (PBS supplemented with
0.4% saponin, 2% goat serum, and 1% bovine serum albumin). Antibodies were diluted in IF buffer and incubated with cells at room temperature
for 1 h (primary antibodies) or 1/2 h (Cy3- or Cy5-conjugated secondary
antibodies). Cultures were washed three times using IF buffer and rocking
between antibody incubations. Cells shown in Fig. 4 were visualized using
an MHFI Olympus FV1000 laser scanning microscope, and images were
processed using Image J. Cells in Fig. 5 were visualized using a Nikon
E-800 microscope, and images were collected using an Orca2 digital camera (Hamamatsu, NJ) controlled by OpenLab software (Improvision,
United Kingdom).
Cell fractionation. Cells were fractionated essentially as described
previously (29). Briefly, cells were trypsinized, pelleted, and resuspended
in 50 mM HEPES, pH 7.2, and 90 mM potassium acetate with protease
inhibitors on ice. Cells were passed through a 27-gauge needle 20 times,
and unbroken cells and nuclei were pelleted at 1,000 ⫻ g for 10 min. The
postnuclear supernatant was separated into cytosolic and membrane fractions by centrifugation at 100,000 ⫻ g.
Western blotting. For budding assays, proteins were dissolved in SDS
sample buffer, boiled for 5 min, resolved in 3 to 20% gradient SDS-polyacrylamide gels, and transferred to nitrocellulose membranes. For fractionation studies, proteins were dissolved in lithium dodecyl sulfate
(LDS) sample buffer, heated to 70°C for 10 min, resolved in 3 to 8%
Tris-acetate gels (Invitrogen), and transferred to nitrocellulose membranes per the supplier’s instructions. Blots were incubated with antibodies diluted in PBS with 5% nonfat milk and 0.05% Tween 20, and bound
HRP-conjugated secondary antibodies were detected by enhanced chemiluminescence.

RESULTS AND DISCUSSION

PVR-NRK cells are productively infected by PV. To test for an
effect of poliovirus on COPII vesicle formation, we utilized permeabilized NRK cells that have a well-characterized secretory
pathway (32). To enable poliovirus infection, NRK cells were engineered to express the human poliovirus receptor. The kinetics of
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FIG 1 NRK cells stably expressing the poliovirus receptor (PVR-NRK) are productively infected by PV and form membranous RCs. (A) PVR-NRK (squares) or
HeLa (circles) cells were infected with PV at an MOI of 10 and incubated at 37°C. At the indicated times postinfection, cells were harvested and lysed by
freeze-thawing, and the number of viral PFU in lysates was determined on HeLa cells as previously described (25). (B) PVR-NRK cells were mock infected (left)
or infected with PV (right) at an MOI of 20. Cells were fixed at 8 h postinfection and visualized by transmission electron microscopy. Bars ⫽ 1 m. Note the
accumulated vesicles in PV-infected cells.

PV production in PVR-NRK cells was compared with that of the
well-characterized human host cell line HeLa. As shown in Fig.
1A, PVR-NRK cells were susceptible to infection by PV (type I
Mahoney strain) and produced infectious virus with kinetics similar to that of HeLa cells, albeit with a slightly lower yield. In addition, transmission electron microscopy of infected PVR-NRK
cells showed robust formation of membranous RCs, as expected
(Fig. 1B).
PV infection transiently increases COPII vesicle release from
semi-intact PVR-NRK cells. To determine if PV infection altered
COPII vesicle biogenesis, we modified a previously described vesicle budding assay (32) to specifically examine endogenous cargoladen COPII vesicles (Fig. 2A). Infected PVR-NRK cells were
scrape permeabilized, and aliquots were added to budding reac-

tion mixtures containing rat liver cytosol and an ATP regeneration system and kept on ice or incubated at 32°C for 30 min. To
assess the specificity of the reactions for COPII vesicle formation,
parallel reactions were performed in the presence of purified dominant-negative mutant (T39N) Sar1 protein, a GDP-restricted
specific inhibitor of COPII vesicle formation (21). Permeabilized
cells were pelleted at 15,000 ⫻ g, the supernatants were collected,
and then released vesicles were pelleted at 100,000 ⫻ g. Pellets
were dissolved in SDS sample buffer, and the amount of vesicles
formed was determined by Western blotting using antibodies to
the COPII membrane cargo protein p24 (4). Relative to the mockinfected cells, there was a 2.3-fold increase in the amount of specific COPII vesicles (total band intensity of 32°C reaction minus
the band intensity of the corresponding sar1dn reaction) formed

FIG 2 PV infection transiently increases COPII vesicle formation. (A) Schematic of vesicle budding assay measuring endogenous cargo-carrying COPII vesicles.
Permeabilized cells are the source of ER for the budding reaction. Soluble proteins required are provided by rat liver cytosol. Released vesicles containing
endogenous cargoes are collected by centrifugation at 100,000 ⫻ g and quantitated by Western blotting using antibodies to the known COPII cargo protein p24.
(B) PVR-NRK cells were mock infected or infected with PV at an MOI of 20 for the indicated times. Cells were permeabilized by scraping and added to vesicle
budding reaction mixtures on ice (white bars) or at 32°C in the absence (black bars) or presence (gray bars) of T39N Sar1 (sardn), an inhibitor of COPII vesicle
formation. Released vesicles and 5% of the input permeabilized cells were analyzed by Western blotting. (Top blot) Results obtained using antibodies to the
endogenous cargo receptor protein p24. (Bottom blot) Results obtained using antibodies to the ER chaperone calnexin. Quantitation of the chemiluminescence
signals from the p24 series is depicted in the graph.
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FIG 3 COPII vesicles formed from semi-intact PV-infected cells are capable of homotypic fusion. (A) Schematic of COPII fusion assay. See the text for details.
(B) COPII vesicle budding of an ER-accumulated model cargo protein, VSV-Gts-myc, is also increased early in PV infection. PVR-NRK cells were transfected
with a plasmid encoding VSV-Gts-myc, and cells were maintained at 40°C to accumulate VSV-Gts-myc in the ER. Transfected cells were infected and permeabilized, and vesicle budding reaction mixtures were kept on ice (white bars) or incubated at 32°C as described in the legend to Fig. 2 (black bars). Released vesicles
were quantitated by Western blotting using the mouse monoclonal anti-myc antibody 9E10. (C) COPII vesicles made from PV-infected cells can fuse homotypically. PVR-NRK cells expressing VSV-Gts-myc were mock infected or infected with PV at an MOI of 50. VSV-Gts-myc-containing vesicles were generated as
described above, in the absence (black bars) or presence (white bars) of the COPII vesicle inhibitor T39N Sar1. VSV-Gts-myc-containing vesicles were mixed with
35
S-labeled untagged VSV-G (VSV-G*)-containing vesicles at 32°C for 1 h. Fused vesicles containing heterotrimers were detected by immunoprecipitating
VSV-Gts-myc and quantitating coprecipitated radioactive VSV-G* by phosphorimaging. The increase in MOI used relative to that for panel B resulted in slightly
faster replication kinetics, resulting in the peak at 2 h postinfection. The graph depicts quantitation of heterotrimers, with background values (for budding
reaction mixtures incubated on ice) subtracted. Error bars represent standard errors of the means (SEM) for duplicate reactions. (D) Phosphorimage of
35
S-labeled vesicles quantitated in panel C.

from cells infected with PV for 3 h, followed by a 5-fold decrease in
the amount formed by cells infected for 6 h (Fig. 2B, black bars).
Vesicle formation was a temperature-dependent process (Fig. 2B,
compare 32°C reaction [black bars] with 0°C reaction [white
bars]) and was significantly inhibited in the presence of the dominant-negative mutant Sar1 protein, indicating that these were
COPII vesicles (Fig. 2B, gray bars). Similar results were obtained
when the vesicles were probed with an antibody to another endogenous COPII vesicle cargo, the SNARE protein rbet1 (data not
shown). The decrease in vesicle formation at late times was expected, as it has been shown that protein secretion is completely
inhibited at this point in infection (9). However, the enhancement
of COPII formation from the ER of cells early in the infection time
course was surprising.
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Vesicle fusion assay. To determine whether the COPII vesicles
formed in PV-infected cells are functional, i.e., capable of homotypic fusion to generate VTCs, we employed a vesicle fusion assay
(32) (Fig. 3A). This assay utilizes vesicles released from two populations of cells expressing unique versions of a model cargo protein, the temperature-sensitive trimeric G protein of the vesicular
stomatitis virus (VSV-Gts). One cell population expresses a transfected myc-tagged version of VSV-Gts and the other cell population expresses an untagged but [35S]methionine-cysteine-labeled
version driven by VSV infection. These cell populations are used
in separate budding reactions to generate COPII vesicles carrying
distinguishable VSV-G trimers. The released vesicles are then
mixed to allow fusion to occur. Upon fusion, the VSV-G trimers
exchange subunits, generating heterotrimers containing a mix-
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FIG 4 Changes in Sec31A-labeled ERES early in PV infection. PVR-NRK cells were mock infected (left) or infected with eGFP-PV at an MOI of 10 for 2 h (middle
and right panels), fixed with 4% paraformaldehyde, permeabilized with 0.4% saponin, and labeled with rabbit anti-Sec31A followed by anti-rabbit Cy3. Nuclei
were visualized using DAPI (4=,6-diamidino-2-phenylindole). Images are z projections collected using an MHFI Olympus FV1000 laser scanning microscope.

ture of myc-tagged cold and untagged radioactive VSV-G subunits. The trimers are immunoprecipitated using an antibody to
the myc tag, and the amount of radioactive VSV-G coprecipitated
is quantified by SDS-PAGE and phosphorimaging. In our adaptation of this assay, the cell population expressing the transfected
myc-tagged VSV-G is mock infected or infected with PV for various times. Vesicles generated from these cells, of unknown fusogenicity, are then mixed with an aliquot of fusion-competent “test
vesicles” (identical in every incubation) derived from the metabolically labeled VSV-infected cells. We have found that VSV infection of the partner cell population, rather than recombinant
expression, is required to generate reliably detectable levels of
[35S]VSV-G counts in the fused vesicles (32). We cannot formally
exclude the possibility that effects of PV infection could be modulated by VSV infection of cells producing the [35S]VSV-G-labeled vesicle.
COPII vesicles formed from semi-intact PV-infected cells are
functional for homotypic fusion. PVR-NRK cells were electroporated with a plasmid encoding myc-tagged VSV-G (VSV-Gtsmyc) and maintained at a restrictive temperature (40°C) to allow
the protein to accumulate within the ER. The transfected cells
were infected with PV for the indicated times as described for Fig.
2B, except that the temperature was maintained at 40°C. Permeabilized cells from these cultures were used in budding reaction
mixtures at 32°C (a permissive temperature), and the movement
of VSV-Gts into COPII vesicles was detected by Western blotting
using the mouse monoclonal anti-myc antibody 9E10 (32). We
again detected an increase in vesicles formed from cells early in
infection followed by a decrease late in infection, confirming that
the alteration in COPII biogenesis seen with endogenous cargo
(Fig. 2B) is also found using overexpressed exogenous cargo
(Fig. 3B).
To assess the fusion competence of these vesicles formed from
PV-infected cells, vesicles from reactions similar to those whose
results are shown in Fig. 3B were mixed with equal amounts of
vesicles prepared from VSV-infected and [35S]methionine-cysteine pulse-labeled cells. The formation of VSV-G heterotrimers
was quantified following anti-myc immunoprecipitation, SDSPAGE, and phosphorimaging to detect radioactive VSV-G. As
shown in Fig. 3C, vesicles formed from cells infected with PV for 2,
3, or 4 h retained the ability to fuse homotypically. The increase in
the fusion signal at 2 hpi is consistent with the enhanced budding
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previously observed (Fig. 2B and 3B). Collectively, the data suggest that PV infection induces an early (2 to 3 hpi) enhancement in
the budding of functional COPII vesicles, followed by a subsequent inhibition by 6 hpi.
Changes in Sec31A labeling of ERES parallel observed
changes in COPII budding. The increase in COPII vesicle formation we observed early in PV infection could be due to a change in
ERES, either quantitatively or qualitatively. To assess this possibility, we labeled infected cells with antibodies to the COPII coat
protein Sec31A, an established marker for ERES (11). We detected
a notable change in Sec31A staining at 2 h postinfection with PV,
with an increase in the brightness of ERES (Fig. 4). The images in
Fig. 4 are representative of findings from four independent experiments. Counting of total puncta/cell by use of Open Lab software
did not show a significant increase in the number of ERES, consistent with the findings of Hsu et al. (14). We did, however, find
that the percentage of “large ERES” (⬎10 pixels) per cell was modestly higher (1.3-fold) for the infected than for the mock-infected
population. These data suggested to us that if a change in ERES
was responsible for the increased COPII budding, then the change
was an increase in size or perhaps a qualitative change in the ERES,
such as an increase in the density of Sec31A on the membrane.
Increased levels of membrane-associated Sec16A indicate
functional changes in ERES early in PV infection. The COPII
vesicle budding reactions used to create Fig. 2 utilized only the
membranes from the infected cells; soluble factors were provided
by added rat liver cytosol. Therefore, it is presumably a change in
a membrane-associated protein that is responsible for the increase
in vesicle budding observed. A prime candidate is Sec16A, a
peripheral membrane protein that is hypothesized to act as a platform for COPII assembly at ERES (27, 31), is required for ERES
formation (6, 7, 19, 31), and stimulates COPII vesicle budding in
vitro in Saccharomyces cerevisiae (28). Perhaps even more relevant
is recent work from several laboratories pointing to a regulatory
role for Sec16A in COPII vesicle formation. The Hauri group has
shown that Sec16 is required for cells to adapt to changes in ER
cargo load and that Sec16 can be phosphorylated via the mitogenactivated protein kinase (MAPK) signaling pathway to increase
the number of ERES per cell (11, 12). Zacharogianni et al. have
shown that in response to amino acid starvation, Sec16 is phosphorylated on its C terminus and loses its association with ER
membranes, resulting in a loss of ERES (34). Most recently, a
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FIG 5 Increase in Sec16A detected by indirect immunofluorescence early in PV infection. PVR-NRK cells were mock infected or infected with eGFP-PV at an
MOI of 10 for 2 or 6 h. Cells were fixed with 4% paraformaldehyde, permeabilized with 0.4% saponin, labeled with rabbit anti-Sec16A followed by anti-rabbit
Cy3, and colabeled with mouse anti-mannosidase II (Mann II) followed by anti-mouse Cy5. Images were collected using a Nikon E-800 wide-field microscope
and an Orca2 digital camera.

paper by Kung et al. showed that Sec16 without an N-terminal
domain can inhibit the GAP activity of Sec23/Sec31 toward Sar1p,
altering the number and size of ERES (22). These studies suggest
that changes in Sec16A could lead to the increase in COPII vesicle
formation we detect early in PV infection.
To probe for any changes in Sec16A upon infection, we labeled
PVR-NRK cells infected with eGFP-PV with antibodies to Sec16A
and the Golgi resident mannosidase II (Fig. 5). There were distinct
changes in Sec16A labeling by 2 h postinfection, with a dramatic
increase in diffuse cytosolic labeling as well as an increase in the
intensity of puncta representing ERES. This result is consistent
with the changes we detected in Sec31A labeling in Fig. 4. These
changes disappeared later in infection (Fig. 5, 6hpi). The mannosidase II staining of the Golgi apparatus was used as an independent indicator of the progression of infection. As evident in the
bottom panels of Fig. 5, the Golgi apparatuses of cells infected for
2 h were mostly intact but fully dispersed by 6 h, consistent with
the eventual shutoff of secretion (9).
If the increase in Sec16A labeling of ERES detected by immunofluorescence represents an increase in the membrane-bound
fraction of Sec16A, this should be detectable by Western blotting
of fractionated cells. At various times post-PV infection, cells were
fractionated as described by Szul et al. (29). Cells were triturated
through a 27-gauge needle and the postnuclear supernatant separated into membrane and cytosol fractions by centrifugation at
100,000 ⫻ g. Proteins were resolved in 3 to 8% Tris-acetate gels
and transferred to nitrocellulose membranes for Western blotting.
The effectiveness of the fractionation method was validated using
antibodies to the transmembrane protein IP3 receptor type I
(IP3RI) and soluble PGK1, as shown in the bottom panels of Fig.
6A. By 2 h after infection with PV, the amount of Sec16 was increased in both membrane and cytosolic pools, consistent with the
changes detected by immunofluorescence (Fig. 6A, top panel, and
B [quantitation]). This PV-induced increase in the membrane
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fraction of Sec16A was, on average, 2-fold (four independent experiments). Also consistent with the immunofluorescence data,
the increase in cytosolic Sec16A was short-lived. When blots were
probed with antibodies to the COPII coat protein Sec31A, we
detected a transient increase in both membrane and cytosolic
pools of a Sec31A doublet (30), in agreement with the immunofluorescence data from Fig. 4. PV infection has been shown to
increase the membrane association of GBF1, a guanine nucleotide
exchange factor for Arf1, a change that occurs early in infection
and is critical to the establishment of RCs (1, 2). In the second
panel of Fig. 6A (quantitation is shown in Fig. 6B), we see a 1.7fold increase in the amount of membrane-bound GBF1 by 2 h
postinfection, indicating that the timing of events is similar, with
membrane-associated Sec16A increasing in parallel with GBF1.
These data suggest that concomitant with the increase in COPII
vesicle budding from ERES early in PV infection, there is a stabilization and/or induction of Sec16A protein resulting in an increase in the amount of membrane-associated Sec16A. In order to
confirm the increase in total Sec16A early in infection, PV- and
mock-infected total cell extracts were directly compared at 3 hpi
by Western blotting using antibodies to Sec16A and IP3RIII (as a
loading control). As shown in Fig. 6C, PV infection resulted in a
1.8-fold increase in the amount of Sec16A, consistent with the cell
fractionation data. We propose that the increase in the functionally relevant membrane fraction of Sec16A is responsible, at least
in part, for the increase in COPII vesicle formation observed.
The increase in COPII vesicles observed early in PV infection of
cells may provide a benefit for either the host cell or the virus. For
the host, this increase in vesicles may be the last opportunity to
present viral antigens by major histocompatibility complex
(MHC) class I molecules before host translation and secretion are
completely inhibited. Clearly, this would be a race between the
virus and the cell, as work from the Kirkegaard group has demonstrated that at similar times postinfection in HeLa cells, there is
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FIG 6 Increases in Sec16A levels in membrane and cytosolic fractions early in PV infection. (A) PVR-NRK cells were mock infected or infected with PV at an
MOI of 50 for 2, 3, or 4 h. Membrane (M) and cytosolic (C) fractions were resolved in 3 to 8% Tris-acetate gels and analyzed by Western blotting using rabbit
polyclonal anti-Sec16A, mouse monoclonal anti-GBF1, rabbit polyclonal anti-Sec31A, rabbit polyclonal anti-IP3RI, and goat polyclonal anti-PGK1 followed by
species-specific peroxidase-conjugated secondary antibodies. (B) Graph of chemiluminescence signals for membrane (black bars) and cytosolic (white bars)
fractions from Sec16A, GBF1, and Sec31A blots quantitated using ImageGauge software (Fujifilm). (C) PVR-NRK cells were mock infected or infected with PV
at an MOI of 50 for 3 h. Cells were trypsinized and counted, equal cell numbers were lysed in 0.25% CHAPS with protease inhibitors, and the protein
concentration in cleared lysates was determined by the Bradford method. Lysates (100 g) were resolved in Tris-acetate gels, and Western analysis was performed
as described for panel A, using rabbit polyclonal anti-Sec16A and mouse monoclonal anti-IP3RIII antibodies. Signals were quantitated, and the ratios for infected
(3 hpi) to mock-infected (0 hpi) cells are displayed.

significant (⬃50%) inhibition of protein secretion (9). If, on the
other hand, the enhanced vesicle formation benefits the virus, one
would expect that blockade of COPII vesicle biogenesis would
inhibit viral replication, and this is indeed the case. Replication of
a PV replicon is reduced 50% by the expression of a dominantnegative mutant of Sar1 (14).
The nature of the early secretory pathway is fundamentally
interconnected—an increase in COPII vesicles leads to an increase
in VTCs, essentially “feeding forward” into the pathway for RC
formation. We propose that a transient burst in COPII vesicles
benefits the virus by increasing the amount of precursor membranes for RC formation and that this change is mediated by the
observed increase in membrane-bound Sec16A. The mechanistic
basis for this change is under investigation.
ACKNOWLEDGMENTS
We thank Jack Nunberg for a critical reading of the manuscript, Lou
Herritt and the MHFI Core at the University of Montana (supported by
National Center for Research Resources award P20RR017670), and Greg
Ning and staff of the electron microscope facility at the Pennsylvania State
University.
This work was supported by grants from the National Institutes of
Health (GM59378 [M.T. and J.C.H.] and AI053531 [H.S.O. and C.E.C.]).

7.
8.

9.
10.

11.

12.

13.

14.
15.
16.
17.

REFERENCES
1. Belov GA, Ehrenfeld E. 2007. Involvement of cellular membrane traffic
proteins in poliovirus replication. Cell Cycle 6:36 –38.
2. Belov GA, et al. 2007. Hijacking components of the cellular secretory
pathway for replication of poliovirus RNA. J. Virol. 81:558 –567.
3. Belov GA, et al. 2012. Complex dynamic development of poliovirus
membranous replication complexes. J. Virol. 86:302–312.
4. Bentley M, et al. 2006. SNARE status regulates tether recruitment and
function in homotypic COPII vesicle fusion. J. Biol. Chem. 281:38825–
38833.
5. Bentley M, et al. 2010. Vesicular calcium regulates coat retention, fusogenicity, and size of pre-Golgi intermediates. Mol. Biol. Cell 21:1033–
1046.
6. Bhattacharyya D, Glick BS. 2007. Two mammalian Sec16 homologues

September 2012 Volume 86 Number 18

18.
19.

20.
21.
22.
23.

have nonredundant functions in endoplasmic reticulum (ER) export and
transitional ER organization. Mol. Biol. Cell 18:839 – 849.
Connerly PL, et al. 2005. Sec16 is a determinant of transitional ER organization. Curr. Biol. 15:1439 –1447.
Crotty S, Hix L, Sigal LJ, Andino R. 2002. Poliovirus pathogenesis in a
new poliovirus receptor transgenic mouse model: age-dependent paralysis
and a mucosal route of infection. J. Gen. Virol. 83:1707–1720.
Doedens JR, Kirkegaard K. 1995. Inhibition of cellular protein secretion
by poliovirus proteins 2B and 3A. EMBO J. 14:894 –907.
Espenshade P, Gimeno RE, Holzmacher E, Teung P, Kaiser CA. 1995.
Yeast SEC16 gene encodes a multidomain vesicle coat protein that interacts with Sec23p. J. Cell Biol. 131:311–324.
Farhan H, Weiss M, Tani K, Kaufman RJ, Hauri HP. 2008. Adaptation
of endoplasmic reticulum exit sites to acute and chronic increases in cargo
load. EMBO J. 27:2043–2054.
Farhan H, et al. 2010. MAPK signaling to the early secretory pathway
revealed by kinase/phosphatase functional screening. J. Cell Biol. 189:
997–1011.
Gimeno RE, Espenshade P, Kaiser CA. 1996. COPII coat subunit interactions: Sec24p and Sec23p bind to adjacent regions of Sec16p. Mol. Biol.
Cell 7:1815–1823.
Hsu NY, et al. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799 – 811.
Hsu VW, Yang JS. 2009. Mechanisms of COPI vesicle formation. FEBS
Lett. 583:3758 –3763.
Hughes H, Stephens DJ. 2008. Assembly, organization, and function of
the COPII coat. Histochem. Cell Biol. 129:129 –151.
Hughes H, et al. 2009. Organisation of human ER-exit sites: requirements
for the localisation of Sec16 to transitional ER. J. Cell Sci. 122:2924 –2934.
Iinuma T, et al. 2007. Mammalian Sec16/p250 plays a role in membrane
traffic from the endoplasmic reticulum. J. Biol. Chem. 282:17632–17639.
Ivan V, et al. 2008. Drosophila Sec16 mediates the biogenesis of tER sites
upstream of Sar1 through an arginine-rich motif. Mol. Biol. Cell 19:4352–
4365.
Klumperman J. 2000. Transport between ER and Golgi. Curr. Opin. Cell
Biol. 12:445– 449.
Kuge O, et al. 1994. Sar1 promotes vesicle budding from the endoplasmic
reticulum but not Golgi compartments. J. Cell Biol. 125:51– 65.
Kung LF, et al. 2011. Sec24p and Sec16p cooperate to regulate the GTP
cycle of the COPII coat. EMBO J. 31:1014 –1027.
Miller S, Krijnse-Locker J. 2008. Modification of intracellular membrane
structures for virus replication. Nat. Rev. Microbiol. 6:363–374.

jvi.asm.org 9681

Trahey et al.

24. Miller EA, Barlowe C. 2010. Regulation of coat assembly—sorting things
out at the ER. Curr. Opin. Cell Biol. 22:447– 453.
25. Oh HS, Pathak HB, Goodfellow IG, Arnold JJ, Cameron CE. 2009.
Insight into poliovirus genome replication and encapsidation obtained
from studies of 3B-3C cleavage site mutants. J. Virol. 83:9370 –9387.
26. Rust RC, et al. 2001. Cellular COPII proteins are involved in production
of the vesicles that form the poliovirus replication complex. J. Virol. 75:
9808 –9818.
27. Shaywitz DA, Espenshade PJ, Gimeno RE, Kaiser CA. 1997. COPII
subunit interactions in the assembly of the vesicle coat. J. Biol. Chem.
272:25413–25416.
28. Supek F, Madden DT, Hamamoto S, Orci L, Schekman R. 2002. Sec16p
potentiates the action of COPII proteins to bud transport vesicles. J. Cell
Biol. 158:1029 –1038.
29. Szul T, et al. 2005. Dissection of membrane dynamics of the ARF-guanine
nucleotide exchange factor GBF1. Traffic 6:374 –385.

9682

jvi.asm.org

30. Tang BL, et al. 2000. Mammalian homologues of yeast sec31p. An ubiquitously expressed form is localized to endoplasmic reticulum (ER) exit
sites and is essential for ER-Golgi transport. J. Biol. Chem. 275:13597–
13604.
31. Watson P, Townley AK, Koka P, Palmer KJ, Stephens DJ. 2006. Sec16
defines endoplasmic reticulum exit sites and is required for secretory
cargo export in mammalian cells. Traffic 7:1678 –1687.
32. Xu D, Hay JC. 2004. Reconstitution of COPII vesicle fusion to generate a
pre-Golgi intermediate compartment. J. Cell Biol. 167:997–1003.
33. Yonekawa S, et al. 2011. Sec16B is involved in the endoplasmic reticulum
export of the peroxisomal membrane biogenesis factor peroxin 16 (Pex16)
in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 108:12746 –12751.
34. Zacharogianni M, et al. 2011. ERK7 is a negative regulator of protein
secretion in response to amino-acid starvation by modulating Sec16
membrane association. EMBO J. 30:3684 –3700.

Journal of Virology

